$ALKS
Alkermes plc.

2022 Q4 Form 10-Q Financial Statement

#000095017022021003 Filed on November 02, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $304.7M $252.4M $294.1M
YoY Change -6.1% -14.21% 11.0%
Cost Of Revenue $53.96M $50.63M $49.56M
YoY Change 0.53% 2.15% 14.99%
Gross Profit $250.7M $201.7M $244.6M
YoY Change -7.41% -17.52% 10.22%
Gross Profit Margin 82.29% 79.94% 83.15%
Selling, General & Admin $157.5M $152.8M $136.2M
YoY Change -1.79% 12.16% 6.67%
% of Gross Profit 62.84% 75.73% 55.69%
Research & Development $101.4M $100.4M $118.4M
YoY Change 3.06% -15.19% 24.64%
% of Gross Profit 40.44% 49.78% 48.41%
Depreciation & Amortization $19.68M $19.60M $19.39M
YoY Change -6.93% 1.06% -5.87%
% of Gross Profit 7.85% 9.71% 7.93%
Operating Expenses $271.3M $253.2M $264.2M
YoY Change 1.08% -4.18% 13.6%
Operating Profit -$20.58M -$60.64M -$19.66M
YoY Change -963.7% 208.46% 83.73%
Interest Expense -$848.0K $3.552M -$1.969M
YoY Change -56.56% -280.4% 392.25%
% of Operating Profit
Other Income/Expense, Net -$258.0K -$6.727M -$5.007M
YoY Change 26.47% 34.35% -137.65%
Pretax Income -$21.69M -$67.37M -$26.54M
YoY Change -9654.19% 153.88% -1306.14%
Income Tax $6.566M -$3.400M $2.453M
% Of Pretax Income
Net Earnings -$28.25M -$63.97M -$28.99M
YoY Change -3336.43% 120.69% 21532.84%
Net Earnings / Revenue -9.27% -25.35% -9.86%
Basic Earnings Per Share -$0.39 -$0.18
Diluted Earnings Per Share -$0.17 -$0.39 -$179.5K
COMMON SHARES
Basic Shares Outstanding 164.3M 164.3M 161.5M
Diluted Shares Outstanding 164.3M 161.5M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $608.5M $580.2M $560.3M
YoY Change 13.45% 3.55% -1.6%
Cash & Equivalents $292.5M $264.0M $310.4M
Short-Term Investments $316.0M $316.2M $249.9M
Other Short-Term Assets $43.53M $40.04M $61.34M
YoY Change -11.11% -34.72% 16.4%
Inventory $181.4M $166.3M $138.7M
Prepaid Expenses
Receivables $296.9M $267.3M $292.7M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.130B $1.054B $1.053B
YoY Change 6.41% 0.08% 2.74%
LONG-TERM ASSETS
Property, Plant & Equipment $325.4M $326.4M $340.6M
YoY Change -4.6% -4.18% -4.12%
Goodwill $92.87M $92.87M $92.87M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $131.6M $166.9M $187.9M
YoY Change -42.64% -11.14% 575.74%
Other Assets $14.69M $10.98M $118.7M
YoY Change -46.49% -90.75% -19.92%
Total Long-Term Assets $833.7M $888.1M $942.4M
YoY Change -13.37% -5.76% 10.63%
TOTAL ASSETS
Total Short-Term Assets $1.130B $1.054B $1.053B
Total Long-Term Assets $833.7M $888.1M $942.4M
Total Assets $1.964B $1.942B $1.995B
YoY Change -2.99% -2.68% 6.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $32.84M $33.20M $36.88M
YoY Change -41.06% -9.97% -55.48%
Accrued Expenses $455.1M $429.4M $406.7M
YoY Change 12.03% 5.57% 42.55%
Deferred Revenue $6.816M $3.982M
YoY Change 7.52%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.000M $3.000M $3.000M
YoY Change 0.0% 0.0% 7.14%
Total Short-Term Liabilities $497.7M $469.6M $453.0M
YoY Change 5.61% 3.66% 19.77%
LONG-TERM LIABILITIES
Long-Term Debt $290.3M $290.9M $293.4M
YoY Change -0.87% -0.86% 7.6%
Other Long-Term Liabilities $42.38M $42.86M $152.8M
YoY Change -2.9% -71.96% 7.94%
Total Long-Term Liabilities $332.7M $333.8M $446.3M
YoY Change -1.13% -25.21% 7.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $497.7M $469.6M $453.0M
Total Long-Term Liabilities $332.7M $333.8M $446.3M
Total Liabilities $920.2M $899.0M $899.3M
YoY Change 0.91% -0.02% 13.47%
SHAREHOLDERS EQUITY
Retained Earnings -$1.699B -$1.671B
YoY Change 10.27%
Common Stock $2.915B $2.887B
YoY Change 4.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.044B $1.043B $1.096B
YoY Change
Total Liabilities & Shareholders Equity $1.964B $1.942B $1.995B
YoY Change -2.99% -2.68% 6.32%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$28.25M -$63.97M -$28.99M
YoY Change -3336.43% 120.69% 21532.84%
Depreciation, Depletion And Amortization $19.68M $19.60M $19.39M
YoY Change -6.93% 1.06% -5.87%
Cash From Operating Activities $1.047M $625.0K $82.78M
YoY Change -96.62% -99.24% 37.5%
INVESTING ACTIVITIES
Capital Expenditures $10.03M -$10.47M -$4.813M
YoY Change -215.78% 117.62% -24.8%
Acquisitions
YoY Change
Other Investing Activities $37.77M $19.37M -$26.89M
YoY Change 376.93% -172.03% 1394.11%
Cash From Investing Activities $27.74M $8.898M -$31.71M
YoY Change -3838.54% -128.06% 286.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -271.0K -212.0K 1.033M
YoY Change -91.48% -120.52% -1133.0%
NET CHANGE
Cash From Operating Activities 1.047M 625.0K 82.78M
Cash From Investing Activities 27.74M 8.898M -31.71M
Cash From Financing Activities -271.0K -212.0K 1.033M
Net Change In Cash 28.52M 9.311M 52.10M
YoY Change 5.23% -82.13% 0.39%
FREE CASH FLOW
Cash From Operating Activities $1.047M $625.0K $82.78M
Capital Expenditures $10.03M -$10.47M -$4.813M
Free Cash Flow -$8.981M $11.10M $87.59M
YoY Change -122.63% -87.33% 31.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Interest Expense
InterestExpense
3552000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.79
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.79
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
Alkermes plc.
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4810000
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2022#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001520262
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35299
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
L2
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1007018
dei Entity Address Address Line1
EntityAddressAddressLine1
Connaught House
dei Entity Address Address Line2
EntityAddressAddressLine2
1 Burlington Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin 4
dei Entity Address Country
EntityAddressCountry
IE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
D04 C5Y6
dei City Area Code
CityAreaCode
353
dei Local Phone Number
LocalPhoneNumber
1-772-8000
dei Security12b Title
Security12bTitle
Ordinary shares, $0.01 par value
dei Trading Symbol
TradingSymbol
ALKS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
164312356
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
263957000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
337544000
CY2022Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
257173000
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
313193000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
316225000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
198767000
CY2022Q3 us-gaap Inventory Net
InventoryNet
166296000
CY2021Q4 us-gaap Inventory Net
InventoryNet
150335000
CY2022Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
10105000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
13363000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
40041000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
48967000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1053797000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1062169000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
326350000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
341054000
CY2022Q3 us-gaap Long Term Investments
LongTermInvestments
166928000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
229430000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
106980000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
115627000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
46845000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
74043000
CY2022Q3 us-gaap Goodwill
Goodwill
92873000
CY2021Q4 us-gaap Goodwill
Goodwill
92873000
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
137149000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
81833000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10977000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
27455000
CY2022Q3 us-gaap Assets
Assets
1941899000
CY2021Q4 us-gaap Assets
Assets
2024484000
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
211177000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
208491000
CY2022Q3 alks Accrued Sales Discounts Allowances And Reserves
AccruedSalesDiscountsAllowancesAndReserves
235640000
CY2021Q4 alks Accrued Sales Discounts Allowances And Reserves
AccruedSalesDiscountsAllowancesAndReserves
237216000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
15756000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16240000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3982000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6339000
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3000000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3000000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
469555000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
471286000
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
290904000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
292804000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
95731000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
104162000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
42855000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
43648000
CY2022Q3 us-gaap Liabilities
Liabilities
899045000
CY2021Q4 us-gaap Liabilities
Liabilities
911900000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
168864804
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
165790549
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
164303229
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
161937327
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
1689000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1658000
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4561575
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3853222
CY2022Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
160561000
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
142658000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2885594000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2798325000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12837000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3723000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1671031000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1541018000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1042854000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1112584000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1941899000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2024484000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
252357000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
294141000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
807121000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
849288000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
50625000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
49561000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
164144000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
143705000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
100430000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
118411000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
289256000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
308152000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
152777000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
136213000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
448206000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
400569000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9166000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9615000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27198000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
28532000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
312998000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
313800000
us-gaap Costs And Expenses
CostsAndExpenses
928804000
us-gaap Costs And Expenses
CostsAndExpenses
880958000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-60641000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-19659000
us-gaap Operating Income Loss
OperatingIncomeLoss
-121683000
us-gaap Operating Income Loss
OperatingIncomeLoss
-31670000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2239000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
468000
us-gaap Investment Income Interest
InvestmentIncomeInterest
3708000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1955000
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2021Q3 us-gaap Interest Expense
InterestExpense
2437000
us-gaap Interest Expense
InterestExpense
8271000
us-gaap Interest Expense
InterestExpense
8814000
CY2022Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-3553000
CY2021Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-5195000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-21750000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-677000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1861000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
288000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2380000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-327000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6727000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6876000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23933000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7863000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-67368000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26535000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-145616000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39533000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3394000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2453000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-15603000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9509000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-63974000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28988000
us-gaap Net Income Loss
NetIncomeLoss
-130013000
us-gaap Net Income Loss
NetIncomeLoss
-49042000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
164282000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
164282000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
161456000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
161456000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
163541000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
163541000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
160642000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
160642000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-63974000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28988000
us-gaap Net Income Loss
NetIncomeLoss
-130013000
us-gaap Net Income Loss
NetIncomeLoss
-49042000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-188000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-72000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-1242000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-325000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2349000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-249000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-9114000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1122000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-66323000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29237000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-139127000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-50164000
us-gaap Profit Loss
ProfitLoss
-130013000
us-gaap Profit Loss
ProfitLoss
-49042000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
58185000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
57510000
us-gaap Share Based Compensation
ShareBasedCompensation
67771000
us-gaap Share Based Compensation
ShareBasedCompensation
68603000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-54073000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2015000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-21750000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-677000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-171000
us-gaap Other Noncash Expense
OtherNoncashExpense
3746000
us-gaap Other Noncash Expense
OtherNoncashExpense
1803000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-56045000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
13991000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-3258000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-10892000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15646000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13375000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1872000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
1507000
alks Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
-12470000
alks Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
-12891000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
15546000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-9191000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4642000
alks Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-13411000
alks Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-12504000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
12424000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4353000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19997000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
70694000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28227000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19359000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
277000
alks Proceeds From Contingent Consideration
ProceedsFromContingentConsideration
1273000
alks Proceeds From Contingent Consideration
ProceedsFromContingentConsideration
7908000
alks Return Of Investments
ReturnOfInvestments
485000
alks Payment Made For Licensed Intellectual Property
PaymentMadeForLicensedIntellectualProperty
1000000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
256806000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
294370000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
190994000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
241082000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-92281000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-65462000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
18850000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
24810000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
17903000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
13633000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
23567000
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
993000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2250000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1500000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1303000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32251000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-73587000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
37483000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
337544000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
272961000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
263957000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
310444000
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
2690000
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
2698000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1112584000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1795000
CY2022Q1 alks Receipt Of Company Stock For Exercise Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Value
ReceiptOfCompanyStockForExerciseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue
-17069000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18494000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-1382000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4511000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-35903000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1075390000
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
16197000
CY2022Q2 alks Receipt Of Company Stock For Exercise Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Value
ReceiptOfCompanyStockForExerciseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue
-514000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23641000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
326000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2254000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-30136000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1082324000
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
858000
CY2022Q3 alks Receipt Of Company Stock For Exercise Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Value
ReceiptOfCompanyStockForExerciseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue
-320000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26315000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-188000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2349000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-63974000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1042854000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1066982000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2053000
CY2021Q1 alks Receipt Of Company Stock For Exercise Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Value
ReceiptOfCompanyStockForExerciseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue
-10413000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15552000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-174000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-601000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-22418000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1051155000
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
18445000
CY2021Q2 alks Receipt Of Company Stock For Exercise Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Value
ReceiptOfCompanyStockForExerciseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue
-707000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26917000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-79000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-272000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
2364000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1097902000
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4312000
CY2021Q3 alks Receipt Of Company Stock For Exercise Of Stock Options Or To Satisfy Minimum Tax Withholding Obligations Related To Stock Based Awards Value
ReceiptOfCompanyStockForExerciseOfStockOptionsOrToSatisfyMinimumTaxWithholdingObligationsRelatedToStockBasedAwardsValue
-2513000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25704000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-72000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-249000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28988000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1096168000
us-gaap Nature Of Operations
NatureOfOperations
<p id="notes_to_financial_statements" style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1. THE</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span id="n1_company"/><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">COMPANY</span></p><p style="text-indent:3.333%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Alkermes plc is a fully-integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to research, develop and commercialize, both with partners and on its own, pharmaceutical products that are designed to address unmet medical needs of patients in the fields of neuroscience and oncology. Alkermes has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, the Company has a research and development (“R&amp;D”) center in Waltham, Massachusetts; an R&amp;D and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio.</span></p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reclassification</span></p><p style="text-indent:3.333%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company reclassified certain prior year amounts on the condensed consolidated balance sheet to conform to the current year presentation. These reclassifications had no impact on the previously reported total assets, liabilities or shareholders’ equity.</span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:3.333%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of the Company’s condensed consolidated financial statements in accordance with GAAP requires that Company management make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, judgments and methodologies, including, but not limited to, those related to revenue from contracts with its customers and related allowances, impairment and amortization of intangibles and long-lived assets, share-based compensation, income taxes including the valuation allowance for deferred tax assets, valuation of investments, contingent consideration and litigation. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different conditions or using different assumptions.</span></p>
CY2022Q3 us-gaap Debt Securities Available For Sale Amortized Cost Noncurrent
DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
172168000
CY2022Q3 alks Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss Noncurrent
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossNoncurrent
4525000
CY2022Q3 alks Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than12 Months Accumulated Loss Non Current
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12MonthsAccumulatedLossNonCurrent
2535000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
165108000
CY2022Q3 alks Long Term Investment Amortized Cost
LongTermInvestmentAmortizedCost
173988000
CY2022Q3 alks Long Term Investment Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
LongTermInvestmentSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
4525000
CY2022Q3 alks Long Term Investment Securities Continuous Unrealized Loss Position More Than12 Months Aggregate Losses
LongTermInvestmentSecuritiesContinuousUnrealizedLossPositionMoreThan12MonthsAggregateLosses
2535000
CY2022Q3 us-gaap Long Term Investments
LongTermInvestments
166928000
CY2022Q3 alks Marketable Securities At Amortized Cost
MarketableSecuritiesAtAmortizedCost
494720000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021Q4 alks Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss Noncurrent
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossNoncurrent
1381000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
227610000
CY2021Q4 alks Long Term Investment Amortized Cost
LongTermInvestmentAmortizedCost
230811000
CY2021Q4 alks Long Term Investment Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
LongTermInvestmentSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
1381000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
229430000
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
13363000
us-gaap Contract With Customer Asset Purchase
ContractWithCustomerAssetPurchase
30215000
us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
33473000
CY2022Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
10105000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
17830000
alks Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
2595000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-5402000
alks Contract With Customer Liability Other Expense Income Net Recognized
ContractWithCustomerLiabilityOtherExpenseIncomeNetRecognized
-6384000
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
8639000
CY2022Q3 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
320732000
CY2022Q3 alks Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Current
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent
4000
CY2022Q3 alks Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss Current
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossCurrent
2994000
CY2022Q3 alks Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss Current
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLossCurrent
1517000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
316225000
CY2022Q3 alks Marketable Investments Securities Unrealized Gain Loss
MarketableInvestmentsSecuritiesUnrealizedGainLoss
4000
CY2022Q3 alks Marketable Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
MarketableSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
7519000
CY2022Q3 alks Marketable Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses
MarketableSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses
4052000
CY2022Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
483153000
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
198596000
CY2021Q4 alks Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Current
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent
287000
CY2021Q4 alks Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss Current
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLossCurrent
116000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
198767000
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost Noncurrent
DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
228991000
CY2021Q4 alks Marketable Securities At Amortized Cost
MarketableSecuritiesAtAmortizedCost
429407000
CY2021Q4 alks Marketable Investments Securities Unrealized Gain Loss
MarketableInvestmentsSecuritiesUnrealizedGainLoss
287000
CY2021Q4 alks Marketable Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses
MarketableSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses
1497000
CY2021Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
428197000
CY2022Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
477000000.0
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
190994000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
239228000
alks Marketable Securities Realized Gain
MarketableSecuritiesRealizedGain
34000
alks Marketable Securities Realized Loss
MarketableSecuritiesRealizedLoss
529000
alks Marketable Securities Realized Loss
MarketableSecuritiesRealizedLoss
977000
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
318866000
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
314355000
CY2022Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
1820000
CY2022Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
1820000
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
174034000
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
166978000
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
492900000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
481333000
CY2022Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
1820000
CY2022Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
1820000
alks Fair Value Recurring Basis Assets Or Liabilities Transfers Between Level One To Level Two
FairValueRecurringBasisAssetsOrLiabilitiesTransfersBetweenLevelOneToLevelTwo
0
alks Fair Value Recurring Basis Assets Or Liabilities Transfers Between Level Two To Level One
FairValueRecurringBasisAssetsOrLiabilitiesTransfersBetweenLevelTwoToLevelOne
0
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
583750000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
536905000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
23048000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
500000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
-21750000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
-1273000
alks Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Impairment Of Corporate Debt Security
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairmentOfCorporateDebtSecurity
-500000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
25000
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0
CY2022Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-3600000
CY2021Q4 us-gaap Business Combination Contingent Consideration Asset
BusinessCombinationContingentConsiderationAsset
23000000.0
CY2021Q4 us-gaap Business Combination Contingent Consideration Asset Current
BusinessCombinationContingentConsiderationAssetCurrent
6400000
CY2021Q4 us-gaap Business Combination Contingent Consideration Asset Noncurrent
BusinessCombinationContingentConsiderationAssetNoncurrent
16600000
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
57889000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
56125000
CY2022Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
79816000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
59105000
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
28591000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
35105000
CY2022Q3 us-gaap Inventory Net
InventoryNet
166296000
CY2021Q4 us-gaap Inventory Net
InventoryNet
150335000
CY2022Q3 alks Inventory Finished Goods Net Of Reserves Located At Third Party Warehouse And Shipping Service Provider
InventoryFinishedGoodsNetOfReservesLocatedAtThirdPartyWarehouseAndShippingServiceProvider
22900000
CY2021Q4 alks Inventory Finished Goods Net Of Reserves Located At Third Party Warehouse And Shipping Service Provider
InventoryFinishedGoodsNetOfReservesLocatedAtThirdPartyWarehouseAndShippingServiceProvider
25100000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
751744000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
736617000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
425394000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
395563000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
326350000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
341054000
CY2022Q3 us-gaap Goodwill Gross
GoodwillGross
92873000
CY2022Q3 us-gaap Goodwill
Goodwill
92873000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
46845000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
35000000.0
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
35000000.0
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1000000.0
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4489000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
17991000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
18148000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
17329000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
18418000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
17535000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
18692000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
17808000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
14661000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
13777000
CY2022Q3 alks Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
95304000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
95229000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
169712000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
179669000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
58225000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
59267000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
111487000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
120402000
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0523
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y10M24D
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
4500000
us-gaap Operating Lease Payments
OperatingLeasePayments
13400000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
4400000
us-gaap Operating Lease Payments
OperatingLeasePayments
12500000
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
4100000
us-gaap Operating Lease Expense
OperatingLeaseExpense
12500000
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
4300000
us-gaap Operating Lease Expense
OperatingLeaseExpense
12900000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
33199000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
55721000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
60920000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
77256000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
117058000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
75514000
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
211177000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
208491000
CY2022Q3 alks Accrued Sales Discounts Allowances And Reserves
AccruedSalesDiscountsAllowancesAndReserves
235640000
CY2021Q4 alks Accrued Sales Discounts Allowances And Reserves
AccruedSalesDiscountsAllowancesAndReserves
237216000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26051000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25600000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
67771000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
68603000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17953000
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16541000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18243000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18876000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3400000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-15600000
us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
0
CY2020Q3 alks Maximum Period Before Fda Can Approve Patent Request
MaximumPeriodBeforeFDACanApprovePatentRequest
P30M

Files In Submission

Name View Source Status
0000950170-22-021003-index-headers.html Edgar Link pending
0000950170-22-021003-index.html Edgar Link pending
0000950170-22-021003.txt Edgar Link pending
0000950170-22-021003-xbrl.zip Edgar Link pending
alks-20220930.htm Edgar Link pending
alks-20220930.xsd Edgar Link pending
alks-ex10_1.htm Edgar Link pending
alks-ex31_1.htm Edgar Link pending
alks-ex31_2.htm Edgar Link pending
alks-ex32_1.htm Edgar Link pending
alks-20220930_cal.xml Edgar Link unprocessable
alks-20220930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
alks-20220930_pre.xml Edgar Link unprocessable
alks-20220930_lab.xml Edgar Link unprocessable
alks-20220930_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
img75676126_0.jpg Edgar Link pending
img75676126_1.jpg Edgar Link pending
img75676126_2.jpg Edgar Link pending
img75676126_3.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending